Topics

Fast track status granted to urothelial cancer candidate

08:05 EDT 26 Mar 2020 | SmartBrief

The FDA will fast track the review of Infiniti Pharmaceuticals' lead candidate IPI-549 as a treatment for advanced urothelial -More

Original Article: Fast track status granted to urothelial cancer candidate

NEXT ARTICLE

More From BioPortfolio on "Fast track status granted to urothelial cancer candidate"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...